Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Hoofdauteur: | Douglas, AD |
---|---|
Andere auteurs: | Draper, SJ |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
2015
|
Onderwerpen: |
Gelijkaardige items
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
door: Kapulu, MC
Gepubliceerd in: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
door: Forbes, E
Gepubliceerd in: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
door: Elias, SC
Gepubliceerd in: (2014) -
Liver-stage vaccines for malaria
door: Longley, RJ
Gepubliceerd in: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
door: Bauza, K
Gepubliceerd in: (2012)